Brief: Ryvu Announces Partial Clinical Hold Of Phase Ib Clinical Trial Of RVU120

Ryvu Therapeutics SA

08/04/2021 23:32

April 8 (Reuters) - Ryvu Therapeutics SA  RVU.WA :
    * RYVU ANNOUNCES PARTIAL CLINICAL HOLD OF PHASE IB CLINICAL
TRIAL
OF RVU120 (SEL120) IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC
SYNDROME
    * RYVU THERAPEUTICS - PARTIAL CLINICAL HOLD INITIATED AFTER
RECENT
REPORT TO FDA OF ADVERSE EVENT INVOLVING PATIENT DEATH POSSIBLY
RELATED TO RVU120

Source text for Eikon:  ID:nPng9xfJa 
Further company coverage:  RVU.WA 

 ((Reuters.Briefs@thomsonreuters.com;))